1. Home
  2. ENVX vs EVO Comparison

ENVX vs EVO Comparison

Compare ENVX & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enovix Corporation

ENVX

Enovix Corporation

HOLD

Current Price

$5.13

Market Cap

1.2B

Sector

Miscellaneous

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$2.01

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENVX
EVO
Founded
2006
1993
Country
United States
Germany
Employees
N/A
4553
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.0B
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
ENVX
EVO
Price
$5.13
$2.01
Analyst Decision
Buy
Strong Buy
Analyst Count
9
1
Target Price
$13.61
$7.00
AVG Volume (30 Days)
5.3M
39.3K
Earning Date
05-13-2026
04-08-2026
Dividend Yield
N/A
N/A
EPS Growth
40.94
N/A
EPS
N/A
N/A
Revenue
$31,821,000.00
N/A
Revenue This Year
$30.37
$1.37
Revenue Next Year
$238.73
$10.05
P/E Ratio
N/A
N/A
Revenue Growth
37.91
N/A
52 Week Low
$4.67
$1.97
52 Week High
$16.49
$4.42

Technical Indicators

Market Signals
Indicator
ENVX
EVO
Relative Strength Index (RSI) 37.82 23.22
Support Level $4.75 N/A
Resistance Level $5.56 $3.36
Average True Range (ATR) 0.38 0.10
MACD -0.06 -0.07
Stochastic Oscillator 18.52 4.27

Price Performance

Historical Comparison
ENVX
EVO

About ENVX Enovix Corporation

Enovix Corp is engaged in designing, developing, manufacturing, and commercializing Lithium-ion, or Li-ion, battery cells. It uses BreakFlow and Encapsulation technologies to manufacture high capacity and resilient batteries. The company's product portfolio comprises power disc batteries, flexible lithium-ion polymer batteries, superior lithium-ion polymer batteries, active silicon lithium-ion cells, and others. Geographically, the company generates maximum revenue from its customers in South Korea, followed by Switzerland, the United States, Norway, Taiwan, and other regions.

About EVO Evotec SE

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.

Share on Social Networks: